May Caitlin, Fleckman Philip, Brandling-Bennett Heather A, Cole Bonnie, Sidbury Robert
Division of Dermatology, Department of Medicine, School of Medicine, University of Washington, Seattle, Washington.
Division of Dermatology, Department of Pediatrics, School of Medicine, Seattle Children's Hospital, University of Washington, Seattle, Washington.
Pediatr Dermatol. 2017 Jul;34(4):e225-e226. doi: 10.1111/pde.13168. Epub 2017 May 23.
We present the case of a 12-year-old-girl who developed lichenoid dermatitis approximately 1 year after starting leflunomide for juvenile idiopathic arthritis. The eruption resolved promptly with discontinuation of the suspected culprit agent, supportive of a lichenoid drug eruption, but she subsequently developed markedly dystrophic nails with lichen planus-like features. A biopsy of her cutaneous findings at the time of initial presentation demonstrated lichenoid dermatitis, and a nail matrix biopsy was deferred given clinical correlation. Prominent nail changes in lichenoid drug eruptions, particularly in children, are rare but should be considered in children with new-onset nail dystrophy.
我们报告了一名12岁女孩的病例,她在开始使用来氟米特治疗幼年特发性关节炎约1年后出现苔藓样皮炎。停用可疑致病药物后皮疹迅速消退,支持苔藓样药物疹的诊断,但随后她出现了具有扁平苔藓样特征的明显营养不良性甲。初次就诊时对其皮肤表现进行活检显示为苔藓样皮炎,鉴于临床相关性,甲母质活检被推迟。苔藓样药物疹中显著的甲改变,尤其是在儿童中,较为罕见,但对于新发甲营养不良的儿童应予以考虑。